ロード中...
A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis
BACKGROUND: Recently, fusion variants of the breast cancer anti-oestrogen-resistance 4 (BCAR4) gene were recurrently discovered in lung adenocarcinoma from the genome-wide studies. However, the functional characterisation of BCAR4 fusion has not been investigated. METHODS: Based on the analysis of R...
保存先:
| 出版年: | Br J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7782829/ https://ncbi.nlm.nih.gov/pubmed/33204025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-01146-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|